# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-044247
Filing Date
2024-04-05
Accepted
2024-04-05 16:03:00
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm248754d4_defa14a.htm | DEFA14A | 16953
2 | GRAPHIC | tm248754d4_defa14aimg001.jpg | GRAPHIC | 388969
3 | GRAPHIC | tm248754d4_defa14aimg002.jpg | GRAPHIC | 270507
| Complete submission text file | 0001104659-24-044247.txt |  | 926622

Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37372 | Film No.: 24826424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)